[73] Outcomes of patients with advanced clear-cell renal cell carcinoma treated by sunitinib as first-line therapy: A prospective observational study in real-world practice of the Academic Hospital of Oran, Algeria

Objective: To investigate the effectiveness of sunitinib as first-line therapy in real-world practice in terms of progression-free survival (PFS), objective response rate (ORR), and overall survival (OS), and to evaluate the safety profile for advanced or metastatic clear-cell renal cell carcinoma (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nadia Ameziane, Louafi Djellali, Mohamed Yamouni, Ali Bazzi, Mostafa Djamal Yousfi, Abderrahmane Attar, Abdelkader Bousahba
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2018
Materias:
Acceso en línea:https://doaj.org/article/5ecc5685575f4e83ab3b6de9d0f97b37
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!